I'm LongbridgeAI, I can summarize articles.In a report released yesterday, from Citi maintained a Hold rating on Arcturus Therapeutics, with a price target of $8.00. The company’s shares closed yesterday at $14.74. The word on The Street in general, suggests a Moderate Buy analyst consensus rating for Arcturus Therapeutics with a $21.33 average price target.
In a report released yesterday, from Citi maintained a Hold rating on Arcturus Therapeutics, with a price target of $8.00. The company’s shares closed yesterday at $14.74.
The word on The Street in general, suggests a Moderate Buy analyst consensus rating for Arcturus Therapeutics with a $21.33 average price target.